Investors with a lot of money to spend have taken a bullish stance on Hims & Hers Health HIMS.
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with HIMS, it often means somebody knows something is about to happen.
So how do we know what these investors just did?
Today, Benzinga's options scanner spotted 29 uncommon options trades for Hims & Hers Health.
This isn't normal.
The overall sentiment of these big-money traders is split between 62% bullish and 27%, bearish.
Out of all of the special options we uncovered, 2 are puts, for a total amount of $551,530, and 27 are calls, for a total amount of $1,895,182.
Predicted Price Range
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $18.5 and $34.0 for Hims & Hers Health, spanning the last three months.
Volume & Open Interest Development
In today's trading context, the average open interest for options of Hims & Hers Health stands at 3237.17, with a total volume reaching 89,815.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Hims & Hers Health, situated within the strike price corridor from $18.5 to $34.0, throughout the last 30 days.
Hims & Hers Health Option Volume And Open Interest Over Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HIMS | PUT | TRADE | BULLISH | 02/21/25 | $6.7 | $6.4 | $6.52 | $24.00 | $521.6K | 0 | 0 |
| HIMS | CALL | SWEEP | BULLISH | 08/16/24 | $3.6 | $3.5 | $3.6 | $19.00 | $124.5K | 18.3K | 7.6K |
| HIMS | CALL | SWEEP | BULLISH | 08/16/24 | $3.7 | $3.6 | $3.7 | $19.00 | $100.6K | 18.3K | 6.8K |
| HIMS | CALL | SWEEP | BULLISH | 08/16/24 | $3.7 | $3.6 | $3.7 | $19.00 | $94.3K | 18.3K | 7.1K |
| HIMS | CALL | TRADE | BEARISH | 08/16/24 | $3.7 | $3.6 | $3.64 | $19.00 | $91.0K | 18.3K | 3.7K |
About Hims & Hers Health
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.
Following our analysis of the options activities associated with Hims & Hers Health, we pivot to a closer look at the company's own performance.
Present Market Standing of Hims & Hers Health
- With a volume of 4,746,422, the price of HIMS is up 4.95% at $21.21.
- RSI indicators hint that the underlying stock may be approaching oversold.
- Next earnings are expected to be released in 25 days.
What The Experts Say On Hims & Hers Health
A total of 4 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $23.0.
- Maintaining their stance, an analyst from TD Cowen continues to hold a Buy rating for Hims & Hers Health, targeting a price of $25.
- Consistent in their evaluation, an analyst from B of A Securities keeps a Buy rating on Hims & Hers Health with a target price of $26.
- An analyst from Jefferies persists with their Hold rating on Hims & Hers Health, maintaining a target price of $23.
- An analyst from Piper Sandler persists with their Neutral rating on Hims & Hers Health, maintaining a target price of $18.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Hims & Hers Health, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
